
Erloday 100mg Tablet
Marketer
Axiommax Oncology Pvt Ltd
Salt Composition
Erlotinib (100mg)
Overview Erloday 100mg Tablet
Erloday 100mg tablets treat non-small cell lung and pancreatic cancers. Administer this medication on an empty stomach, or at least one hour before or two hours after eating. Continue treatment as directed by your physician; duration depends on individual response. Strictly adhere to your doctor's prescription; improper usage or overdose can lead to severe complications. Therapeutic effects may not be apparent for weeks or months; do not discontinue without medical guidance. Common side effects include nausea, vomiting, tiredness, skin rash, and weight loss. Severe diarrhea warrants increased fluid intake or medical consultation. Photosensitivity is possible; wear protective clothing and sunscreen outdoors. Report mouth sores, vision changes, or breathing problems immediately. Regular liver function monitoring may be necessary. Inform your healthcare provider of all medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is crucial for both partners. Smoking cessation is advised as it may interfere with treatment efficacy. Maintain a two-hour interval between Erloday and antacids or other medications.
Primary Ingredients of Erloday 100mg Tablet
No text provided to rephrase.
Uses of Erloday 100mg Tablet
Cancers of the pancreas and non-small-cell lung
Major Benefits of Erloday 100mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Erloday 100mg Tablet on an empty stomach.
Common Side effects of Erloday 100mg Tablet:
- Abdominal pain
- Bone pain
- Breathlessness
- Constipation
- Cough
- Diarrhea
- Fatigue
- Fever
- Infection
- Muscle pain
- Nausea
- Rash
- Stomatitis (Inflammation of the mouth)
- Vomiting
- Weight loss
How to use Erloday 100mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Erloday 100mg Tablet on an empty stomach.
How Erloday 100mg Tablet works:
Erloday 100mg tablets combat lung cancer by targeting epidermal growth factor receptors (EGFR). These receptors, present on lung cancer cells, stimulate their growth. The medication functions by attaching to EGFR, thus blocking the cancer-promoting signals they transmit and consequently limiting tumor expansion.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Erloday 100mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Erloday 100mg tablets during pregnancy carries a confirmed risk to the fetus. Prescribing may occur in exceptional, life-threatening circumstances where potential benefits outweigh known hazards, but only under a physician's direction. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Erloday 100mg tablets is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Driving ability while taking Erloday 100mg Tablets is undetermined. Refrain from driving if concentration or reaction time is impaired.
KidneySAFE IF PRESCRIBED
Erloday 100mg tablets are considered safe for individuals with kidney impairment; no dosage alteration is necessary. However, its use is contraindicated in patients experiencing severe kidney dysfunction.
LiverCAUTION
Patients with hepatic impairment should use Erloday 100mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Erloday 100mg Tablet :
Omit any missed Erloday 100mg Tablet dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Erloday 100mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Quinazoline-based compound |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
